Subscribe to RSS
DOI: 10.1055/s-0034-1379215
Synthesis of γ-Sanshool and Hydroxy-γ-sanshool
Publication History
Received: 31 July 2014
Accepted after revision: 05 September 2014
Publication Date:
16 October 2014 (online)
Abstract
Members of the family of polyunsaturated amide compounds known as the sanshools are found in various Zanthoxylum species such as Sichuan (or Szechuan) peppercorns (huajiao). γ-Sanshool and hydroxy-γ-sanshool have been synthesized from simple building blocks using an alkyne to (E,E)-1,3-diene isomerization reaction to stereoselectively install the (E,E)-2,4-diene group of the key synthetic intermediate (2E,4E,8Z,10E,12E)-tetradecapentaenoic acid, which in turn was converted into both γ-sanshool and hydroxy-γ-sanshool by reaction with the appropriate amines.
#
The sanshools are a family of polyunsaturated fatty acid amides found in various Zanthoxylum species that has recently attracted the interest of a broad cross-section of the scientific community (Figure [1]).[1] For example, hydroxy-α-sanshool (HAS) is responsible for the numbing/tingling sensation one experiences when eating Sichuan (or Szechuan) peppercorns (huajiao),[2] and this finding has led to interest in understanding the details of its mechanism of action[3] and in developing various medicinal,[4] agricultural,[5] food,[6] and cosmetic[7] applications for it. However, while HAS has been relatively widely studied, it is rather difficult to obtain it in pure form.[8] While much less is known regarding the other sanshools,[9] γ-sanshool (1) has been found to inhibit human acyl-CoA cholesterol acyltransferase-1, with an IC50 of 12 μM.[10] Thus, in order to increase the availability of the sanshools for wider study, we have initiated a program to synthesize them in stereochemically pure form and have recently reported a synthesis of HAS that can be performed on a gram scale.[11] [12] [13] [14] In this report, we describe the synthesis of 1 and hydroxy-γ-sanshool (2) from a common carboxylic acid intermediate.


The synthesis of 1 has been previously described by two groups, and in both syntheses a Horner–Wadsworth–Emmons (HWE) reaction was used to construct the 2,4-diene group (Scheme [1]).[15] [16] In the report published nearly 30 years ago by Crombie and Fisher, several synthetic strategies were described, but in the preferred route the C2–C3 double bond was formed from a HWE reaction.[15a] The authors did not discuss the stereoselectivity of this HWE reaction, but in the subsequent synthesis of 1 described by Igarashi et al., a similar HWE reaction used to form the C4–C5 double bond resulted in either a mixture of E and Z isomers, or only modest (40–56%) yield of the desired product.[16] Therefore, it seems that the synthesis by Crombie and Fisher possibly suffered from similar issues. Furthermore, both syntheses utilized amide-functionalized phosphonate reagents in the HWE reactions, which resulted in dienamide products. Thus, these two routes only resulted in the synthesis of 1 and do not involve an intermediate directly amenable to the synthesis of analogues of it in which the N-substituent varies, as it does in 2. With these issues regarding this pervious work in mind, we felt that it would be useful to design a synthesis of 1 in which the issue of stereoisomers in the 2,4-diene group is eliminated and that involves a carboxylic acid, which could also be used to generate not only 2, but a library of other amide analogues as well.


Our retrosynthetic strategy for 1, and thus 2, is depicted in Scheme [2]. As outlined above, carboxylic acid 3 was targeted as the key synthetic intermediate since it could conceivably be converted into a wide range of amides, and it might be prepared from alkynoate 4 using a stereoselective alkyne to (E,E)-1,3-diene isomerization reaction,[17] [18] followed by saponification. The alkyne group of 4 could presumably be formed by a Corey–Fuchs reaction on aldehyde 5 using methyl chloroformate to trap the acetylide intermediate to install the ester moiety. Aldehyde 5 in turn might be generated by adjusting the oxidation state of ester 6, which itself might be synthesized via a Z-selective Wittig reaction between commercially available sorbaldehyde (7) and the phosphonium salt derived from 8.


The successful implementation of our synthetic plan is presented in Scheme [3].[19] Alkyl halide 8 was converted into the corresponding phosphonium salt 9 in high yield by reaction with triphenylphospine, and this in turn was used in a Wittig reaction with aldehyde 7 using excess Cs2CO3 in warm CH2Cl2 to afford ester 6 as a mixture of Z and E stereoisomers (ca. 3:1 ratio). These were not separated, and the mixture was directly reduced using DIBAL-H to afford aldehyde 5 in high yield. Next, conversion of aldehyde 5 into alkynoate 4 was achieved in a three-stage Corey–Fuchs procedure using methyl chloroformate as the electrophile in good overall yield. Gratifyingly, the envisioned isomerization of 4 proceeded with high stereoselectivity in the presence of the combination of triphenylphospine and phenol in warm toluene to afford penultimate intermediate 10 in high yield. Saponification of 10 afforded solid carboxylic acid 3, which could be recrystallized to a high level of stereochemical homogeneity using a combination of CHCl3 and hexane. Finally, amide formation using the appropriate amine afforded 1 [20] and 2 [21] in 28% and 29% overall yield, respectively, from 8. It should be noted that commercially available 7 is labeled as being ‘predominantly trans,trans’, and is approximately a 5:1 mixture of stereoisomers according to 1H NMR analysis. Thus, the relatively modest 63% yield for the saponification of 10 to form carboxylic acid 3 is quite respectable since the isomers formed due to the impurity of 7 and during the Wittig reaction are removed during this step.


In summary, we report a concise, stereoselective, and high-yielding route for the synthesis of both 1 and 2 from simple and commercially available building blocks. Notably, carboxylic acid 3 can be recrystallized to purity, and its use as the immediate precursor to 1 and 2 allows for the synthesis of amide analogues of these natural products. We are currently investigating the application of our previously reported methods for using polymer-supported reagents and catalysts in Wittig[22] and alkyne-isomerization[23] reactions to the synthesis of 3, and it is hoped that this work will further facilitate the study of the sanshools by making them and their analogues more easily available.
#
Acknowledgement
This research was supported financially by the University of Hong Kong and the Research Grants Council of the Hong Kong S. A. R., P. R. of China (Project No. HKU 705510P).
Supporting Information
- for this article is available online at http://www.thieme-connect.com.accesdistant.sorbonne-universite.fr/products/ejournals/journal/
10.1055/s-00000083.
- Supporting Information
-
References and Notes
- 1a Crombie L. J. Chem. Soc. 1955; 998
- 1b Crombie L, Tayler JL. J. Chem. Soc. 1957; 2760
- 1c Yasuda I, Takeya K, Itokawa H. Chem. Pharm. Bull. 1981; 29: 1791
- 1d Yasuda I, Takeya K, Itokawa H. Phytochemistry 1982; 21: 1295
- 1e Mizutani K, Fukunaga Y, Tanaka O, Takasugi N, Saruwatari Y.-I, Fuwa T, Yamauchi T, Wang J, Jia M.-R, Li F.-Y, Ling Y.-K. Chem. Pharm. Bull. 1988; 36: 2362
- 1f Kashiwada Y, Ito C, Katagiri H, Mase I, Komatsu K, Namba T, Ikeshiro Y. Phytochemistry 1997; 44: 1125
- 1g Xiong Q, Shi D, Yamamoto H, Mizuno M. Phytochemistry 1997; 46: 1123
- 1h Chen I.-S, Chen T.-L, Lin W.-Y, Tsai I.-L, Chen Y.-C. Phytochemistry 1999; 52: 357
- 1i Iseli V, Potterat O, Hagmann L, Egli J, Hamburger M. Pharmazie 2007; 62: 396
- 1j Jang KH, Chang YH, Kim D.-D, Oh K.-B, Oh U, Shin J. Arch. Pharm. Res. 2008; 31: 569
- 1k Yang X. J. Agric. Food Chem. 2008; 56: 1689
- 1l Machmudah S, Izumi T, Sasaki M, Goto M. Sep. Purif. Technol. 2009; 68: 159
- 1m Huang S, Zhao L, Zhou XL, Ying M, Wang CJ, Weng J. Chin. Chem. Lett. 2012; 23: 1247
- 2a Bryant BP, Mezine I. Brain Res. 1999; 842: 452
- 2b Sugai E, Morimitsu Y, Iwasaki Y, Morita A, Watanabe T, Kubota K. Biosci. Biotechnol. Biochem. 2005; 69: 1951
- 3a Koo JY, Jang Y, Cho H, Lee C.-H, Jang KH, Chang YH, Shin J, Oh U. Eur. J. Neurosci. 2007; 26: 1139
- 3b Bautista DM, Sigal YM, Milstein AD, Garrison JL, Zorn JA, Tsuruda PR, Nicoll RA, Julius D. Nat. Neurosci. 2008; 11: 772
- 3c Riera CE, Menozzi-Smarrito C, Affolter M, Michlig S, Munari C, Robert F, Vogel H, Simon SA, le Coutre J. Br. J. Pharmacol. 2009; 157: 1398
- 3d Lennertz RC, Tsunozaki M, Bautista DM, Stucky CL. J. Neurosci. 2010; 30: 4353
- 3e Tsunozaki M, Lennertz RC, Vilceanu D, Katta S, Stucky CL, Bautista DM. J. Physiol. 2013; 591: 3325
- 3f Bader M, Stark TM, Dawid C, Lösch S, Hofmann T. J. Agric. Food Chem. 2014; 62: 2479
- 4a Baraldi PG, Preti D, Materazzi S, Geppetti P. J. Med. Chem. 2010; 53: 5085
- 4b Mathie A. J. Pharm. Pharmacol. 2010; 62: 1089
- 4c Es-Salah-Lamoureux Z, Steele DF, Fedida D. Trends Pharmacol. Sci. 2010; 31: 587
- 5 Tang X, Zhou X, Wu J, Li J, Bai L. Pestic. Biochem. Physiol. 2014; 110: 44
- 6 Starkenmann C, Cayeux I, Birkbeck AA. Chimia 2011; 65: 407
- 7 Artaria C, Maramaldi G, Bonfigli A, Rigano L, Appendino G. Int. J. Cosmetic Sci. 2011; 33: 328
- 8 According to Bautista et al.,3b 50 g of dried seeds from Zanthoxylum piperitum afforded 55.2 mg of crude HAS after preparative HPLC. Repetitive chromatographic separation was required to further purify 1 to homogeneity.
- 9a Navarrete A, Hong E. Planta Med. 1996; 62: 250
- 9b Dossou KS. S, Devkota KP, Morton C, Egan JM, Lu G, Beutler JA, Moaddel R. J. Nat. Prod. 2013; 76: 2060
- 10 Park Y.-D, Lee WS, An S, Jeong TS. Biol. Pharm. Bull. 2007; 30: 205
- 11 Wu B, Li K, Toy PH. Synlett 2012; 23: 2564
- 12 For the synthesis of α-sanshool, see: Sonnet PE. J. Org. Chem. 1969; 34: 1147
- 13 For another synthesis of HAS and hydroxy-β-sanshool, see: Igarashi Y, Aoki K, Nishimura H, Morishita I, Usui K. Chem. Pharm. Bull. 2012; 60: 1088
- 14 For the synthesis and evaluation of simplified analogues of HAS, see: Menozzi-Smarrito C, Riera CE, Munari C, le Coutre J, Robert F. J. Agric. Food Chem. 2009; 57: 1982
- 15a Crombie L, Fisher D. Tetrahedron Lett. 1985; 26: 2477
- 15b Crombie L, Fisher D. Tetrahedron Lett. 1985; 26: 2481
- 16 Aoki K, Igarashi Y, Nishimura H, Morishita I, Usui K. Tetrahedron Lett. 2012; 53: 6000
- 17a Trost BM, Kazmaier U. J. Am. Chem. Soc. 1992; 114: 7933
- 17b Guo C, Lu X. J. Chem. Soc., Chem. Commun. 1993; 394
- 17c Rychnovsky SD, Kim J. J. Org. Chem. 1994; 59: 2659
- 17d Strunz GM, Finlay HJ. Can. J. Chem. 1996; 74: 419
- 17e Kwong CK.-W, Fu MY, Lam CS.-L, Toy PH. Synthesis 2008; 2307
- 17f Fu MY, Guo J, Toy PH. Synlett 2011; 989
- 18 For a recent example of the application of this reaciton in complex natural product synthesis, see: Wang Y, O’Doherty GA. J. Am. Chem. Soc. 2013; 135: 9334
- 19 See Supporting Information for details.
- 20 Characterization Data for 11c 1H NMR (400 MHz, CDCl3): δ = 0.92 (d, 6 H, J = 6.5 Hz), 1.78 (d, 3 H, J = 6.5 Hz), 1.81 (q, 1 H, J = 6.5 Hz), 2.25 (t, 2 H, J = 6.7 Hz), 2.30 (t, 2 H, J = 6.7 Hz), 3.15 (t, 2 H, J = 6.5 Hz), 5.36 (dt, 1 H, J 1 = 9.7 Hz, J 2 = 7.4 Hz), 5.72 (dt, 1 H, J 1 = 14.0 Hz, J 2 = 7.0 Hz), 5.81 (d, 1 H, J = 15.2 Hz), 5.85 (s, 1 H), 5.99–6.20 (m, 5 H), 6.29–6.33 (m, 1 H), 7.17 (dd, 1 H, J 1 = 14.6 Hz, J 2 = 10.7 Hz). 13C NMR (100 MHz, CDCl3): δ = 18.4, 20.2, 27.2, 28.7, 33.0, 47.0, 122.4, 125.4, 128.9, 129.5, 130.0, 130.1, 132.0, 133.4, 141.0, 141.8, 166.5. MS: m/z calcd for C18H27NO: 273.2; found: 273.2.
- 21 Characterization Data for 21e 1H NMR (400 MHz, CDCl3): δ = 1.22 (s, 6 H), 1.78 (d, 3 H, J = 6.7 Hz), 2.25 (t, 2 H, J = 6.7 Hz), 2.30 (t, 2 H, J = 6.7 Hz), 3.33 (d, 2 H, J = 5.9 Hz), 5.35 (dt, 1 H, J 1 = 10.1 Hz, J 2 = 7.5 Hz), 5.72 (dt, 1 H, J 1 = 14.0 Hz, J 2 = 6.8 Hz), 5.84 (d, 1 H, J = 15.0 Hz), 5.99–6.02 (m, 5 H), 6.29–6.36 (m, 1 H), 7.19 (dd, 1 H, J 1 = 15.0 Hz, J 2 = 10.4 Hz). 13C NMR (100 MHz, CDCl3): δ = 18.4, 27.1, 27.3, 33.0, 50.6, 71.0, 121.9, 125.4, 128.8, 129.6, 130.0, 130.1, 131.9, 133.5, 141.6, 142.4, 167.7. MS: m/z calcd for C18H27NO2: 289.2; found: 289.2.
- 22a Leung PS.-W, Teng Y, Toy PH. Synlett 2010; 1997
- 22b Leung PS.-W, Teng Y, Toy PH. Org. Lett. 2010; 12: 4996
- 22c Teng Y, Lu J, Toy PH. Chem. Asian J. 2012; 7: 351
- 23 Kwong CK.-W, Fu MY, Law HC.-H, Toy PH. Synlett 2010; 2617
-
References and Notes
- 1a Crombie L. J. Chem. Soc. 1955; 998
- 1b Crombie L, Tayler JL. J. Chem. Soc. 1957; 2760
- 1c Yasuda I, Takeya K, Itokawa H. Chem. Pharm. Bull. 1981; 29: 1791
- 1d Yasuda I, Takeya K, Itokawa H. Phytochemistry 1982; 21: 1295
- 1e Mizutani K, Fukunaga Y, Tanaka O, Takasugi N, Saruwatari Y.-I, Fuwa T, Yamauchi T, Wang J, Jia M.-R, Li F.-Y, Ling Y.-K. Chem. Pharm. Bull. 1988; 36: 2362
- 1f Kashiwada Y, Ito C, Katagiri H, Mase I, Komatsu K, Namba T, Ikeshiro Y. Phytochemistry 1997; 44: 1125
- 1g Xiong Q, Shi D, Yamamoto H, Mizuno M. Phytochemistry 1997; 46: 1123
- 1h Chen I.-S, Chen T.-L, Lin W.-Y, Tsai I.-L, Chen Y.-C. Phytochemistry 1999; 52: 357
- 1i Iseli V, Potterat O, Hagmann L, Egli J, Hamburger M. Pharmazie 2007; 62: 396
- 1j Jang KH, Chang YH, Kim D.-D, Oh K.-B, Oh U, Shin J. Arch. Pharm. Res. 2008; 31: 569
- 1k Yang X. J. Agric. Food Chem. 2008; 56: 1689
- 1l Machmudah S, Izumi T, Sasaki M, Goto M. Sep. Purif. Technol. 2009; 68: 159
- 1m Huang S, Zhao L, Zhou XL, Ying M, Wang CJ, Weng J. Chin. Chem. Lett. 2012; 23: 1247
- 2a Bryant BP, Mezine I. Brain Res. 1999; 842: 452
- 2b Sugai E, Morimitsu Y, Iwasaki Y, Morita A, Watanabe T, Kubota K. Biosci. Biotechnol. Biochem. 2005; 69: 1951
- 3a Koo JY, Jang Y, Cho H, Lee C.-H, Jang KH, Chang YH, Shin J, Oh U. Eur. J. Neurosci. 2007; 26: 1139
- 3b Bautista DM, Sigal YM, Milstein AD, Garrison JL, Zorn JA, Tsuruda PR, Nicoll RA, Julius D. Nat. Neurosci. 2008; 11: 772
- 3c Riera CE, Menozzi-Smarrito C, Affolter M, Michlig S, Munari C, Robert F, Vogel H, Simon SA, le Coutre J. Br. J. Pharmacol. 2009; 157: 1398
- 3d Lennertz RC, Tsunozaki M, Bautista DM, Stucky CL. J. Neurosci. 2010; 30: 4353
- 3e Tsunozaki M, Lennertz RC, Vilceanu D, Katta S, Stucky CL, Bautista DM. J. Physiol. 2013; 591: 3325
- 3f Bader M, Stark TM, Dawid C, Lösch S, Hofmann T. J. Agric. Food Chem. 2014; 62: 2479
- 4a Baraldi PG, Preti D, Materazzi S, Geppetti P. J. Med. Chem. 2010; 53: 5085
- 4b Mathie A. J. Pharm. Pharmacol. 2010; 62: 1089
- 4c Es-Salah-Lamoureux Z, Steele DF, Fedida D. Trends Pharmacol. Sci. 2010; 31: 587
- 5 Tang X, Zhou X, Wu J, Li J, Bai L. Pestic. Biochem. Physiol. 2014; 110: 44
- 6 Starkenmann C, Cayeux I, Birkbeck AA. Chimia 2011; 65: 407
- 7 Artaria C, Maramaldi G, Bonfigli A, Rigano L, Appendino G. Int. J. Cosmetic Sci. 2011; 33: 328
- 8 According to Bautista et al.,3b 50 g of dried seeds from Zanthoxylum piperitum afforded 55.2 mg of crude HAS after preparative HPLC. Repetitive chromatographic separation was required to further purify 1 to homogeneity.
- 9a Navarrete A, Hong E. Planta Med. 1996; 62: 250
- 9b Dossou KS. S, Devkota KP, Morton C, Egan JM, Lu G, Beutler JA, Moaddel R. J. Nat. Prod. 2013; 76: 2060
- 10 Park Y.-D, Lee WS, An S, Jeong TS. Biol. Pharm. Bull. 2007; 30: 205
- 11 Wu B, Li K, Toy PH. Synlett 2012; 23: 2564
- 12 For the synthesis of α-sanshool, see: Sonnet PE. J. Org. Chem. 1969; 34: 1147
- 13 For another synthesis of HAS and hydroxy-β-sanshool, see: Igarashi Y, Aoki K, Nishimura H, Morishita I, Usui K. Chem. Pharm. Bull. 2012; 60: 1088
- 14 For the synthesis and evaluation of simplified analogues of HAS, see: Menozzi-Smarrito C, Riera CE, Munari C, le Coutre J, Robert F. J. Agric. Food Chem. 2009; 57: 1982
- 15a Crombie L, Fisher D. Tetrahedron Lett. 1985; 26: 2477
- 15b Crombie L, Fisher D. Tetrahedron Lett. 1985; 26: 2481
- 16 Aoki K, Igarashi Y, Nishimura H, Morishita I, Usui K. Tetrahedron Lett. 2012; 53: 6000
- 17a Trost BM, Kazmaier U. J. Am. Chem. Soc. 1992; 114: 7933
- 17b Guo C, Lu X. J. Chem. Soc., Chem. Commun. 1993; 394
- 17c Rychnovsky SD, Kim J. J. Org. Chem. 1994; 59: 2659
- 17d Strunz GM, Finlay HJ. Can. J. Chem. 1996; 74: 419
- 17e Kwong CK.-W, Fu MY, Lam CS.-L, Toy PH. Synthesis 2008; 2307
- 17f Fu MY, Guo J, Toy PH. Synlett 2011; 989
- 18 For a recent example of the application of this reaciton in complex natural product synthesis, see: Wang Y, O’Doherty GA. J. Am. Chem. Soc. 2013; 135: 9334
- 19 See Supporting Information for details.
- 20 Characterization Data for 11c 1H NMR (400 MHz, CDCl3): δ = 0.92 (d, 6 H, J = 6.5 Hz), 1.78 (d, 3 H, J = 6.5 Hz), 1.81 (q, 1 H, J = 6.5 Hz), 2.25 (t, 2 H, J = 6.7 Hz), 2.30 (t, 2 H, J = 6.7 Hz), 3.15 (t, 2 H, J = 6.5 Hz), 5.36 (dt, 1 H, J 1 = 9.7 Hz, J 2 = 7.4 Hz), 5.72 (dt, 1 H, J 1 = 14.0 Hz, J 2 = 7.0 Hz), 5.81 (d, 1 H, J = 15.2 Hz), 5.85 (s, 1 H), 5.99–6.20 (m, 5 H), 6.29–6.33 (m, 1 H), 7.17 (dd, 1 H, J 1 = 14.6 Hz, J 2 = 10.7 Hz). 13C NMR (100 MHz, CDCl3): δ = 18.4, 20.2, 27.2, 28.7, 33.0, 47.0, 122.4, 125.4, 128.9, 129.5, 130.0, 130.1, 132.0, 133.4, 141.0, 141.8, 166.5. MS: m/z calcd for C18H27NO: 273.2; found: 273.2.
- 21 Characterization Data for 21e 1H NMR (400 MHz, CDCl3): δ = 1.22 (s, 6 H), 1.78 (d, 3 H, J = 6.7 Hz), 2.25 (t, 2 H, J = 6.7 Hz), 2.30 (t, 2 H, J = 6.7 Hz), 3.33 (d, 2 H, J = 5.9 Hz), 5.35 (dt, 1 H, J 1 = 10.1 Hz, J 2 = 7.5 Hz), 5.72 (dt, 1 H, J 1 = 14.0 Hz, J 2 = 6.8 Hz), 5.84 (d, 1 H, J = 15.0 Hz), 5.99–6.02 (m, 5 H), 6.29–6.36 (m, 1 H), 7.19 (dd, 1 H, J 1 = 15.0 Hz, J 2 = 10.4 Hz). 13C NMR (100 MHz, CDCl3): δ = 18.4, 27.1, 27.3, 33.0, 50.6, 71.0, 121.9, 125.4, 128.8, 129.6, 130.0, 130.1, 131.9, 133.5, 141.6, 142.4, 167.7. MS: m/z calcd for C18H27NO2: 289.2; found: 289.2.
- 22a Leung PS.-W, Teng Y, Toy PH. Synlett 2010; 1997
- 22b Leung PS.-W, Teng Y, Toy PH. Org. Lett. 2010; 12: 4996
- 22c Teng Y, Lu J, Toy PH. Chem. Asian J. 2012; 7: 351
- 23 Kwong CK.-W, Fu MY, Law HC.-H, Toy PH. Synlett 2010; 2617







